vs
LINKBANCORP, Inc.（LNKB）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是LINKBANCORP, Inc.的1.5倍（$69.8M vs $46.0M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 6.4%，领先377.6%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 7.3%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 6.6%）
LINKBANCORP是一家总部位于美国的银行控股公司，主要为宾夕法尼亚州地区的个人消费者、小微企业和中型企业提供零售与商业银行服务，涵盖存款账户、贷款产品、财富管理解决方案及数字银行服务等核心业务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
LNKB vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.5倍
$46.0M
营收增速更快
RIGL
高出13.9%
7.3%
净利率更高
RIGL
高出377.6%
6.4%
两年增速更快
RIGL
近两年复合增速
6.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $46.0M | $69.8M |
| 净利润 | $2.9M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 8.5% | 33.2% |
| 净利率 | 6.4% | 384.0% |
| 营收同比 | 7.3% | 21.2% |
| 净利润同比 | -61.2% | 1769.2% |
| 每股收益（稀释后） | $0.08 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LNKBRIGL
| Q4 25 | $46.0M | $69.8M | ||
| Q3 25 | $44.8M | $69.5M | ||
| Q2 25 | $42.3M | $101.7M | ||
| Q1 25 | $53.4M | $53.3M | ||
| Q4 24 | $42.9M | $57.6M | ||
| Q3 24 | $42.9M | $55.3M | ||
| Q2 24 | $41.3M | $36.8M | ||
| Q1 24 | $40.5M | $29.5M |
净利润LNKBRIGL
| Q4 25 | $2.9M | $268.1M | ||
| Q3 25 | $7.8M | $27.9M | ||
| Q2 25 | $7.4M | $59.6M | ||
| Q1 25 | $15.3M | $11.4M | ||
| Q4 24 | $7.6M | $14.3M | ||
| Q3 24 | $7.1M | $12.4M | ||
| Q2 24 | $5.8M | $-1.0M | ||
| Q1 24 | $5.7M | $-8.2M |
毛利率LNKBRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率LNKBRIGL
| Q4 25 | 8.5% | 33.2% | ||
| Q3 25 | 22.3% | 40.9% | ||
| Q2 25 | 22.4% | 60.1% | ||
| Q1 25 | 36.0% | 23.9% | ||
| Q4 24 | 22.6% | 28.9% | ||
| Q3 24 | 21.3% | 25.4% | ||
| Q2 24 | 18.0% | 1.2% | ||
| Q1 24 | 18.1% | -23.6% |
净利率LNKBRIGL
| Q4 25 | 6.4% | 384.0% | ||
| Q3 25 | 17.5% | 40.2% | ||
| Q2 25 | 17.5% | 58.6% | ||
| Q1 25 | 28.7% | 21.5% | ||
| Q4 24 | 17.7% | 24.9% | ||
| Q3 24 | 16.5% | 22.5% | ||
| Q2 24 | 14.1% | -2.8% | ||
| Q1 24 | 14.1% | -27.9% |
每股收益（稀释后）LNKBRIGL
| Q4 25 | $0.08 | $14.11 | ||
| Q3 25 | $0.21 | $1.46 | ||
| Q2 25 | $0.20 | $3.28 | ||
| Q1 25 | $0.41 | $0.63 | ||
| Q4 24 | $0.21 | $0.82 | ||
| Q3 24 | $0.19 | $0.70 | ||
| Q2 24 | $0.16 | $-0.06 | ||
| Q1 24 | $0.15 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $52.3M | $155.0M |
| 总债务越低越好 | $177.3M | $52.5M |
| 股东权益账面价值 | $306.4M | $391.5M |
| 总资产 | $3.1B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.58× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资LNKBRIGL
| Q4 25 | $52.3M | $155.0M | ||
| Q3 25 | $194.2M | $137.1M | ||
| Q2 25 | $155.1M | $108.4M | ||
| Q1 25 | $220.2M | $77.1M | ||
| Q4 24 | $166.1M | $77.3M | ||
| Q3 24 | $191.2M | $61.1M | ||
| Q2 24 | $181.7M | $49.1M | ||
| Q1 24 | $172.3M | $49.5M |
总债务LNKBRIGL
| Q4 25 | $177.3M | $52.5M | ||
| Q3 25 | $102.3M | $60.0M | ||
| Q2 25 | $102.3M | $60.0M | ||
| Q1 25 | $102.7M | $60.0M | ||
| Q4 24 | $112.5M | $60.0M | ||
| Q3 24 | $102.4M | $60.0M | ||
| Q2 24 | $102.3M | $60.0M | ||
| Q1 24 | $102.2M | $60.0M |
股东权益LNKBRIGL
| Q4 25 | $306.4M | $391.5M | ||
| Q3 25 | $305.5M | $117.6M | ||
| Q2 25 | $298.0M | $81.9M | ||
| Q1 25 | $294.1M | $18.6M | ||
| Q4 24 | $280.2M | $3.3M | ||
| Q3 24 | $277.4M | $-14.6M | ||
| Q2 24 | $271.4M | $-29.9M | ||
| Q1 24 | $268.2M | $-31.7M |
总资产LNKBRIGL
| Q4 25 | $3.1B | $513.6M | ||
| Q3 25 | $3.1B | $242.5M | ||
| Q2 25 | $2.9B | $206.7M | ||
| Q1 25 | $2.9B | $176.0M | ||
| Q4 24 | $2.9B | $164.0M | ||
| Q3 24 | $2.9B | $139.4M | ||
| Q2 24 | $2.9B | $128.4M | ||
| Q1 24 | $2.8B | $126.5M |
负债/权益比LNKBRIGL
| Q4 25 | 0.58× | 0.13× | ||
| Q3 25 | 0.33× | 0.51× | ||
| Q2 25 | 0.34× | 0.73× | ||
| Q1 25 | 0.35× | 3.23× | ||
| Q4 24 | 0.40× | 18.25× | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.38× | — | ||
| Q1 24 | 0.38× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $25.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $23.8M | — |
| 自由现金流率自由现金流/营收 | 51.7% | — |
| 资本支出强度资本支出/营收 | 3.2% | — |
| 现金转化率经营现金流/净利润 | 8.59× | 0.08× |
| 过去12个月自由现金流最近4个季度 | $55.3M | — |
8季度趋势，按日历期对齐
经营现金流LNKBRIGL
| Q4 25 | $25.3M | $22.0M | ||
| Q3 25 | $23.6M | $24.0M | ||
| Q2 25 | $6.3M | $30.5M | ||
| Q1 25 | $2.6M | $-893.0K | ||
| Q4 24 | $25.4M | $14.5M | ||
| Q3 24 | $14.0M | $21.7M | ||
| Q2 24 | $6.4M | $302.0K | ||
| Q1 24 | $-771.0K | $-5.0M |
自由现金流LNKBRIGL
| Q4 25 | $23.8M | — | ||
| Q3 25 | $23.2M | — | ||
| Q2 25 | $6.1M | — | ||
| Q1 25 | $2.2M | — | ||
| Q4 24 | $22.6M | — | ||
| Q3 24 | $13.1M | — | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $-1.2M | — |
自由现金流率LNKBRIGL
| Q4 25 | 51.7% | — | ||
| Q3 25 | 51.8% | — | ||
| Q2 25 | 14.5% | — | ||
| Q1 25 | 4.2% | — | ||
| Q4 24 | 52.6% | — | ||
| Q3 24 | 30.5% | — | ||
| Q2 24 | 15.3% | — | ||
| Q1 24 | -3.0% | — |
资本支出强度LNKBRIGL
| Q4 25 | 3.2% | — | ||
| Q3 25 | 0.8% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.7% | — | ||
| Q4 24 | 6.7% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 1.1% | — |
现金转化率LNKBRIGL
| Q4 25 | 8.59× | 0.08× | ||
| Q3 25 | 3.01× | 0.86× | ||
| Q2 25 | 0.85× | 0.51× | ||
| Q1 25 | 0.17× | -0.08× | ||
| Q4 24 | 3.35× | 1.01× | ||
| Q3 24 | 1.97× | 1.75× | ||
| Q2 24 | 1.10× | — | ||
| Q1 24 | -0.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
